HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

imigliptin

a dipeptidyl peptidase IV inhibitor; antidiabetic activity; structure in first source

Also Known As:

KBP-3853

Networked: 4 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - imigliptin: 4
  - Pyridines: 88
    - imigliptin: 4

Experts

1.	Hu, Pei: 3 articles (01/2021 - 08/2018)
2.	Liu, Dongyang: 3 articles (01/2021 - 08/2018)
3.	Liu, Hongzhong: 3 articles (01/2021 - 08/2018)
4.	Liu, Yang: 3 articles (01/2021 - 08/2018)
5.	Ma, Xifeng: 3 articles (11/2018 - 08/2014)
6.	Zhou, Huimin: 3 articles (11/2018 - 08/2014)
7.	Jiang, Ji: 2 articles (11/2018 - 08/2018)
8.	Shi, Chongtie: 2 articles (11/2018 - 08/2018)
9.	Song, Ling: 2 articles (11/2018 - 08/2018)
10.	Yao, Xueting: 2 articles (11/2018 - 08/2018)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 08/05/2018 - "Imigliptin has been reported as a novel dipeptidyl-peptidase-IV (DPP-4) inhibitor to treat type 2 Diabetes Mellitus (T2DM), and is currently being tested in clinical trials. " 11/01/2018 - "Imigliptin is a novel DPP-4 inhibitor, designed to treat type 2 diabetes mellitus (T2DM). " 08/14/2014 - "Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes." 01/01/2021 - "Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes."
2.	Insulin Resistance 01/01/2021 - "In the present study, we aimed to evaluate the effects of imigliptin and alogliptin on insulin resistance and beta-cell function in Chinese patients with type-2 diabetes mellitus (T2DM). "
3.	Diabetes Mellitus 01/01/2021 - "In the present study, we aimed to evaluate the effects of imigliptin and alogliptin on insulin resistance and beta-cell function in Chinese patients with type-2 diabetes mellitus (T2DM). "

Related Drugs and Biologics

1.	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
2.	alogliptin
3.	Dipeptidyl-Peptidase IV Inhibitors